Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: October 14, 2020
Risk factors for disease progression in idiopathic pulmonary fibrosis.
Journal: Thorax
Published: May 23, 2019
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 29, 2017
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Journal: Journal of hepatology
Published: August 20, 2017
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.
Journal: The Lancet. Respiratory medicine
Published: August 17, 2016
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression.
Journal: The European respiratory journal
Published: November 02, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026